Letter to the editor: bevacizumab in refractory gastrointestinal bleeding after liver transplant: an alternative for persistent angiodysplasias. // Journal of Liver Transplantation. – URL: https://www.sciencedirect.com/science/article/pii/S2666967626000632?dgcid=rss_sd_all
Letter to the editor: bevacizumab in refractory gastrointestinal bleeding after liver transplant: an alternative for persistent angiodysplasias. Journal of Liver Transplantation. https://www.sciencedirect.com/science/article/pii/S2666967626000632?dgcid=rss_sd_all
“Letter to the editor: bevacizumab in refractory gastrointestinal bleeding after liver transplant: an alternative for persistent angiodysplasias.” Journal of Liver Transplantation.
@article{article53779,
title = {Letter to the editor: bevacizumab in refractory gastrointestinal bleeding after liver transplant: an alternative for persistent angiodysplasias},
journal = {Journal of Liver Transplantation},
url = {https://www.sciencedirect.com/science/article/pii/S2666967626000632?dgcid=rss_sd_all}
}